Life sciences companies in emerging markets face shrinking net prices, rising production and distribution costs, and tougher competition. Executives expect discounting to rise by 30% in the next 3–5 years, pressuring margins. Seven levers can help: segmentation and targeting, lean go-to-market models, marketing mix optimization, outsourcing sales to CSOs, renegotiating distributors, strengthening GTN strategy, and long-term capability building. AI/ML enhances efficiency via demand forecasting, personalized marketing, procurement optimization, and dynamic pricing. Success requires clear priorities, cross-functional buy-in, and robust KPIs to monitor progress.

Join for free to read